Recent research published in the Archives of Dermatological Research investigates the potential role of ChatGPT in streamlining Mohs surgery consultations. The study, led by Shah, K.M., Davis, M.J., and Alshaikh, H., delves into the possibility of utilizing AI to enhance the dialogue between patients and dermatological specialists. By analyzing the needs and expectations of both healthcare providers and patients, the research aims to ascertain whether AI can improve access to information, expedite responses, and provide reliable support during the consultation process.

Generative AI models like ChatGPT have shown significant promise in various fields, ranging from customer service to educational contexts. Their ability to process vast amounts of information and generate coherent, contextually relevant responses positions them as valuable tools in healthcare environments. In the context of Mohs surgery, effective communication is paramount, as it involves complex decision-making that can significantly impact patient outcomes. Therefore, understanding how AI can contribute to this type of specialized conversation is vital.

The research explores several dimensions of effectiveness, focusing on the AI’s ability to provide accurate, timely, and empathetic responses to patient inquiries. It emphasizes that while ChatGPT can simulate conversational engagement, crucial elements such as emotional intelligence and contextual understanding remain challenging. Nevertheless, the potential for AI to function as a triage tool is profound; it could assist patients in determining whether a consultation with a specialist is warranted, thereby optimizing the use of medical resources.

Moreover, the study examines the implications of AI-driven consultations on healthcare workflows. By automating preliminary assessments and providing patients with essential information about the Mohs surgical process, AI can allow dermatologists to dedicate more time to complex cases that require nuanced decision-making. This shift can enhance the overall efficiency of dermatological practices while simultaneously improving patient experiences through faster response times and reduced wait periods.

Central to the research is the acknowledgment of the inherent challenges associated with implementing AI in medical consultations. Issues such as data privacy, ethical considerations, and the need for continuous updates to ensure accuracy are paramount. The authors advocate for a collaborative approach, where AI is viewed as a complementary resource rather than a replacement for human expertise. In this regard, the concept of “human-in-the-loop” systems becomes relevant, as it allows for the integration of AI capabilities while retaining the irreplaceable value of human judgment in clinical settings.

Patient engagement is another critical aspect explored in the study. The research posits that the use of AI tools may foster a greater sense of involvement among patients by providing them with instant access to information and the ability to pose their questions in real time. This could facilitate deeper discussions during consultations, empowering patients to take an active role in their healthcare journey. Encouraging patient autonomy aligns with contemporary trends in healthcare, where informed decision-making is increasingly prioritized.

Importantly, the findings indicate a potential shift in the doctor-patient relationship facilitated by AI. While traditional consultations often position the physician as the primary authority, the inclusion of AI can democratize information, allowing patients to engage more as equals in the medical dialogue. This paradigm shift could foster enhanced trust and openness, which are essential for successful therapeutic relationships.

The study also highlights the scalability of using AI in Mohs surgery consultations. Providing patients with AI-facilitated resources could allow healthcare systems to manage larger populations efficiently, especially in areas where specialist access is limited. This scalability has the potential to bridge healthcare disparities by ensuring that more individuals receive timely information about skin cancer detection and treatment options.

While the research offers compelling insights, it also calls for further studies to validate the effectiveness of AI in various clinical scenarios. Understanding the limitations of current AI technologies is crucial for their responsible implementation. Continuous evaluation of AI performance in real-world consultations will illuminate areas for improvement and adaptation to meet the nuanced demands of medical dialogues.

As healthcare systems continue to grapple with increasing patient loads and the necessity for more efficient service delivery, AI tools like ChatGPT could emerge as pivotal players. The blending of technology with human expertise may well redefine the contours of patient consultations, creating pathways for novel interactions that enhance care quality.

In summary, the ongoing exploration of AI’s role in medical consultations, specifically in Mohs surgery, presents a multitude of opportunities and challenges. This research invites healthcare professionals to engage with AI technologies proactively, ensuring they are well-prepared to harness their capabilities effectively. By maintaining a careful oversight of the integration process, the medical community can pave the way for improved patient experiences and outcomes through innovative solutions.

Subject of Research: The potential of ChatGPT in facilitating Mohs surgery consultations.

Article Title: Can ChatGPT facilitate Mohs surgery consultation?

Article References: Shah, K.M., Davis, M.J., Alshaikh, H. et al. Can ChatGPT facilitate Mohs surgery consultation?. Arch Dermatol Res 318, 41 (2026). https://doi.org/10.1007/s00403-025-04513-3

Image Credits: AI Generated

DOI: 10.1007/s00403-025-04513-3

Keywords: Artificial Intelligence, Dermatology, Mohs Surgery, Patient Consultation, Healthcare Innovation.

The study highlights the powerful potential of LLMs like OpenAI’s ChatGPT, which are reshaping the way information is accessed, processed, and utilized in nursing and healthcare at large. These models, trained on vast datasets, can generate coherent and contextually relevant text, opening new avenues for patient education, clinical decision-making, and research synthesis. However, with this potential comes a responsibility to critically evaluate the implications of AI technologies in clinical settings and education, fostering a balanced discourse.

Zhou et al.’s research utilized a systematic approach to analyze editorials from prominent nursing journals. By examining the tone, content, and context of published articles, the study aimed to uncover underlying attitudes toward LLMs. The study’s findings indicate a varied landscape of acceptance and skepticism, emphasizing the complexity of integrating AI into nursing practices. This variation reflects broader societal debates about technology adoption in sensitive fields like healthcare, where the stakes are particularly high.

Moreover, the researchers identified specific themes that characterized the discourse around LLMs. One prevalent theme was the promise of improving patient communication. Many editorial pieces highlighted LLMs as tools that can facilitate clearer, more personalized patient interactions, thus enhancing the overall quality of care. The ability of LLMs to process patient data and generate tailored informational content positions them as valuable adjuncts in nursing and patient education.

However, alongside the optimism lies a significant cautionary perspective. The risks associated with over-reliance on AI, including misinformation propagation and ethical dilemmas surrounding patient data privacy, were prominent in many editorials. The research underscores the necessity of maintaining the human touch in nursing, ensuring that technological interventions do not compromise the essential humanistic aspects of care that are fundamental to the profession.

The editorial analysis conducted by Zhou and colleagues also revealed a spectrum of knowledge and familiarity with LLMs among nursing professionals. Some editors expressed a cautious embrace of AI technologies, advocating for ongoing education and training to equip nurses with the necessary skills to leverage these tools effectively. Others voiced concerns about the generational gap in technology adoption, emphasizing the importance of inclusive approaches that consider diverse perspectives within the nursing community.

The study further underscores the significance of collaborative efforts. As LLMs continue to evolve, the need for interdisciplinary dialogue among healthcare professionals, technologists, and educators becomes increasingly critical. By fostering an environment of collaboration, the healthcare community can better navigate the complexities introduced by AI integration, ensuring that technological advancements align with ethical standards and enhance patient outcomes.

Additionally, there is a call to action for nursing journals to provide platforms for these discussions. The editorial landscape must evolve to include not just critical analysis of LLMs but also proactive strategies to assess their applications in practice. As editorial stances continue to shape the narrative surrounding technology in nursing, it is imperative that these publications lead by example, promoting evidence-based discourse that is rooted in the realities of patient care.

The implications of Zhou et al.’s findings extend beyond the academic realm; they serve as a wake-up call for policymakers as well. Understanding the editorial sentiments toward LLMs can inform health policy initiatives aimed at integrating innovative technologies into healthcare systems. By recognizing both the opportunities and challenges posed by these models, stakeholders can create supportive frameworks that enable safe and effective implementation in clinical settings.

Furthermore, Zhou’s study highlights the urgency of conducting more empirical research on the impact of LLM interventions in nursing practice. While editorials provide valuable insights, they represent an initial step in understanding how these technologies affect patient care and outcomes. Call for longitudinal studies and real-world experiments could provide deeper insights into the efficacy of incorporating LLMs into clinical workflows.

In conclusion, the cross-sectional analysis presented by Zhou and colleagues serves as a critical reference point for understanding current perceptions of LLMs in nursing. As healthcare continues to embrace technology, it is vital for nursing professionals to engage in ongoing conversations about the benefits and challenges of AI integration. By fostering an open dialogue, the nursing community can navigate the complexities of AI while upholding its commitment to quality, compassionate care. The findings highlight a pivotal juncture, where the potential of LLMs can be harnessed for the betterment of nursing practice, but only through careful consideration, collaboration, and an unwavering focus on patient outcomes.

In the realm of healthcare, the intersection of technology and human care is not just a trend; it is the future. As nursing journals grapple with the ramifications of LLM integration, they must prioritize discussions that lead to informed decision-making, paving the way for a future where technology supports, rather than supplants, the essence of nursing.

In navigating this complex landscape, the need for a shared understanding of LLMs among nurses and healthcare professionals is crucial. Emphasizing education and training within nurse curricula on the ethical implications of AI can equip future generations with the critical thinking skills needed to assess and adapt to new technologies effectively. The nursing profession is beautifully unique, underpinned by empathy, and as we embrace the power of AI, it is essential that we safeguard these attributes at the forefront of patient care.

Ultimately, the analysis of editorial stances is more than an academic exercise; it marks a crucial step in defining how nursing will respond to the inevitable integration of artificial intelligence in the coming years. By fostering a balanced discourse, rooted in evidence-based practice, the nursing community can strategically position itself as a leader in the AI revolution within healthcare, ensuring that technological advancements serve as catalysts for compassion and care rather than points of contention.

Subject of Research: Editorial stances on large language models in nursing publications.

Article Title: Editorial Stances on Large Language Models in Leading Nursing Publications: A Cross-Sectional Analysis

Article References: Zhou, X., Su, G., Zhu, L. et al. Editorial stances on large Language models in leading nursing publications: a cross-sectional analysis. BMC Nurs 24, 1419 (2025). https://doi.org/10.1186/s12912-025-04102-9

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12912-025-04102-9

Keywords: large language models, nursing, editorial analysis, healthcare technology, artificial intelligence, patient care.

The burgeoning use of AI-powered chatbots like ChatGPT in medicine is driven by a growing demand from patients for instantaneous, accessible medical information. Yet, skepticism remains warranted, especially when AI dispenses advice on specialized and continually updating topics such as cancer treatment. Justin Taylor, M.D., a physician-scientist at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine and senior author of the study, emphasizes cautious optimism. He warns that while AI tools may assist in patient education, the intricacies of personalized cancer care require physician oversight and consultation to prevent misinformation.

The research focused on ChatGPT version 3.5, the widely accessible iteration available in mid-2024. Unlike the latest AI models built on more current datasets, ChatGPT 3.5’s training data were capped around 2021. This temporal limitation presents a critical barrier, especially for hematologic oncology—a field in which therapeutic protocols evolve rapidly in response to ongoing clinical trials, novel drug approvals, and expanding molecular understanding of diseases such as leukemia, lymphoma, and multiple myeloma.

To rigorously evaluate performance, the researchers constructed ten representative questions that mimic those a patient might pose during various cancer care stages. Half the questions addressed broad, foundational concerns common at diagnosis—such as generalized chemotherapy side effects and their management strategies. The remaining five tackled more nuanced, emerging topics, including novel targeted agents like BCL-2 inhibitors, which hold promise in personalized hematologic therapeutics but remain part of active research pipelines.

Four hematology-oncology physicians conducted blinded assessments of the AI-generated answers, rating each response on a five-point scale from “strongly disagree” to “strongly agree” regarding accuracy, completeness, and relevance. Results revealed a clear trend: ChatGPT 3.5 scored moderately well on general questions, averaging 3.38—a neutral to somewhat positive accuracy range. However, when challenged with detailed queries surrounding newer therapies, its average rating dipped to 3.06, reflecting increased ambiguity and partial incompleteness.

Remarkably, none of the AI’s responses achieved a top score of five, highlighting the current insufficiency of ChatGPT 3.5 in providing fully authoritative or exhaustive explanations in such a specialized medical domain. This underscores the intrinsic challenge for large language models trained primarily on static datasets: they lack real-time integration with cutting-edge clinical research data and human expert consensus needed to navigate complex treatment landscapes.

The study’s conclusions urge healthcare providers and patients alike to maintain a balanced view of AI-generated medical information. Dr. Taylor draws parallels with the early era of internet-driven patient education, when Google searches surged but quality control lagged. Over time, clinicians adapted by guiding patients toward vetted resources, fostering shared understanding rooted in credible evidence. He envisions a similar evolution in AI usage, where chatbots serve as initial educational tools that prepare patients for informed discussions rather than replace professional guidance.

This research notably fills a significant gap in the literature by concentrating on hematology-oncology, a subfield where treatment regimens must be meticulously tailored to individual genetic and molecular profiles. Unlike more static medical domains, blood cancer care integrates dynamic elements such as biomarker-driven drug selection and adaptive protocols based on patient response. These complexities render AI’s current abilities insufficient for independent clinical decision-making.

Beyond clinical accuracy, the study points to a promising future synergy between AI and medical education. At the University of Miami’s Miller School of Medicine, AI applications are already easing physician workload by automating summary reports and streamlining documentation. Educational initiatives include elective courses focused on AI’s role in medicine and ethics training tailored to diverse linguistic populations, indicating a holistic institutional commitment to responsibly integrating AI technology.

The addition of AI-powered diagnostic tools, such as systems designed for brain tumor identification through optical imaging and machine learning algorithms predicting outcomes for multiple myeloma, exemplifies the expanding frontier of AI in oncology. As these technologies mature, they hold the potential to revolutionize both diagnostic precision and therapeutic decision support, complementing rather than supplanting human expertise.

Looking ahead, Dr. Taylor and his colleagues plan to revisit AI accuracy in hematologic oncology with newer iterations of ChatGPT and related large language models, anticipating improvements reflecting expanded data input and algorithmic refinement. Nevertheless, the core premise remains: AI’s role should be as an augmentative aid, enhancing patient engagement and facilitating physician-patient communication rather than acting as a standalone source of medical advice.

This landmark study serves as a timely reminder of AI’s dual nature in healthcare—brimming with transformative promise while still encumbered by fundamental limitations. It spotlights the imperative for continuous physician oversight and evidence-based validation as AI tools become woven into the fabric of cancer care. In this critical balance lies the pathway toward harnessing AI’s power without compromising the nuance and compassion essential to effective medicine.

Subject of Research: Hematologic cancers; AI application in oncology; evaluation of ChatGPT 3.5 in medical information accuracy
Article Title: ChatGPT’s Role in the Rapidly Evolving Hematologic Cancer Landscape
News Publication Date: September 3, 2025
Web References: https://doi.org/10.1080/20565623.2025.2546259
Image Credits: Photo by Sylvester Comprehensive Cancer Center